Ariad gets $25M milestone payment from Merck
[Copy proxy address to clipboard]
Ariad Pharmaceuticals Inc. will be getting a $25 million milestone payment from partner Merck, as the bone cancer drug they are working on has moved further toward approval in the European Union, just months after the deal between the two companies was expanded.
2011-08-18 23:12:15